Clinical News: Page 260

Nomograms help predict positive Pylarify scans in prostate cancer patients
By Will Morton
Wednesday, November 30 | 12:15 p.m.-12:45 p.m. | W5A-STCE-2 | Learning Center TheaterNomograms may help guide the selection of the most suitable prostate cancer patients for F-18 DCFPyL-PET/CT (Pylarify) imaging, according to research presented in this session.
November 21, 2022
Pylarify improves management of patients considered for FT
By Will Morton
Wednesday, November 30 | 9:30 a.m.-10:30 a.m. | W3-SSNMMI06-1 | Room S502The role of F-18 DCFPyL (Pylarify) PET/MRI in the management of men considered for focal ablative therapies (FT) will be discussed in this session, with results suggesting the approach may exclude nearly 30% of patients from focal therapy.
November 21, 2022
Ga-68 PSMA-11 PET changes management for most patients
By Will Morton
Wednesday, November 30 | 9:30 a.m.-10:30 a.m. | W3-SSNMMI06-2 | Room S502Gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 PET/CT and PET/MRI resulted in patient management changes in most clinical trial participants with prostate cancer, according to research presented in this session.
November 21, 2022
F-18 FDOPA best for imaging adrenal tumors related to MEN 2
By Will Morton
Tuesday, November 29 | 1:30 p.m.-2:00 p.m. | T6-STCE-4 | Learning Center TheaterIn this molecular imaging scientific session, researchers will make the case that F-18 fluorodopa (FDOPA) should be the radiotracer of choice among four evaluated for diagnosing adrenal gland tumors related to multiple endocrine neoplasia type 2 (MEN 2).
November 21, 2022
SSR-PET/CT outperforms biopsy for diagnosing liver NET metastases
By Will Morton
Tuesday, November 29 | 9:30 a.m.-10:30 a.m. | T3-SSNMMI05-5 | Room E351In this scientific session, a retrospective study will be presented that evaluated the accuracy of somatostatin receptor (SSR)-PET/CT for detecting liver metastases in differentiated neuroendocrine tumors (NETs).
November 21, 2022
FDG-PET/CT improves management of patients with sarcomas
By Will Morton
Sunday, November 27 | 10:30 a.m.-11:30 a.m. | S2-SSNMMI01-4 | Room E352In this scientific session, a study will be presented on the impact of F-18 FDG-PET/CT imaging on initial staging, restaging, clinical management, and outcomes for patients with soft-tissue and bone sarcomas.
November 21, 2022
FDG-PET/MRI can guide breast cancer therapy changes
By Amerigo Allegretto
Sunday, November 27 | 9:00 a.m.-9:30 a.m. | S1-STCE-3 | Learning Center TheaterIn this talk, researchers will discuss how F-18 FDG-PET/MRI leads to therapy changes in breast cancer patients with elevated pretest probability for distant metastases.
November 21, 2022
Road to RSNA 2022: Molecular Imaging Preview
By Will Morton
This year's nuclear medicine and molecular imaging program at RSNA 2022 resounds with the impact of theranostics on the lives of patients with prostate cancer, with prostate-specific membrane antigen PET imaging taking center stage. Organizers even saw fit to title one scientific session "Prostate and Theranostics Potpourri."
November 21, 2022
Susceptibility-weighted MRI shows brain changes in COVID-19 patients
By Kate Madden Yee
Susceptibility-weighted MRI reveals that patients who have recovered from COVID-19 show changes in their brains up to six months later, according to research to be presented at the upcoming RSNA meeting.
November 20, 2022
2022 11 21 04 02 4919 2022 11 21 Brain Abnormalities 20221121042148
MRI casts doubt on the benefits of taking NSAIDs for arthritis
By Kate Madden Yee
MRI has shown that taking nonsteroidal anti-inflammatory drugs (NSAIDs) for osteoarthritis in the knee joint may actually make inflammation worse, according to research to be presented at the upcoming RSNA meeting in Chicago.
November 20, 2022
2022 11 21 03 29 7185 2022 11 21 Rsna Pr Fat Pad 20221121035526
Lunit secures 2 European certifications
By AuntMinnie.com staff writers
Artificial intelligence (AI) software developer Lunit has secured two European certifications for its Insight CXR and Insight MMG AI radiology software.
November 20, 2022
2020 03 04 21 21 6197 Artificial Intelligence Ai Hand 400 20200304215813
ACR releases updated fluoroscopy patient radiation dose index
By Will Morton
An American College of Radiology (ACR) task force has released the first radiation dose index registry for fluoroscopy procedures in 20 years. The report was published November 12 in the Journal of Vascular and Interventional Radiology.
November 20, 2022
2019 02 15 18 26 2638 Interventional Radiology 400
Previous Page
Page 260 of 3690
Next Page